ScreenerHero

BIM bioMérieux S.A.

EPA · FR · Healthcare · Diagnostics & Research · biomerieux.com
80.10EUR+2.50%Mkt Cap: 10.27B $P/E: 20.54

bioMérieux S.A. develops, manufactures, and markets in vitro diagnostic solutions for infectious diseases in France, Europe, Africa, the Middle East, North and South America, the Asia Pacific, and internationally. It ope…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$250.23BUSDP/E 36.4
DHR
Danaher Corporation
$155.51BUSDP/E 39.4
NTRA
Natera, Inc.
$61.35BUSD
LONN
Lonza Group AG
$45.93BUSDP/E 38.2
A
Agilent Technologies, Inc.
$48.29BUSDP/E 33.8
ILMN
Illumina, Inc.
$44.35BUSDP/E 54.8
IQV
IQVIA Holdings Inc.
$43.80BUSDP/E 33.1
WAT
Waters Corporation
$43.21BUSDP/E 111.4
IDXX
IDEXX Laboratories, Inc.
$41.58BUSDP/E 37.0
MTD
Mettler-Toledo International Inc.
$30.89BUSDP/E 34.7
DGX
Quest Diagnostics Incorporated
$25.63BUSDP/E 24.7
GH
Guardant Health, Inc.
$25.12BUSD
LH
Labcorp Holdings Inc.
$25.03BUSDP/E 25.5
RVTY
Revvity, Inc.
$17.56BUSDP/E 75.3
MEDP
Medpace Holdings, Inc.
$17.32BUSDP/E 36.4
CRL
Charles River Laboratories International, Inc.
$14.84BUSD
ERF
Eurofins Scientific SE
$14.16BUSDP/E 26.4
ICLR
ICON Public Limited Company
$12.99BUSDP/E 177.2
QGEN
Qiagen N.V.
$9.46BUSDP/E 23.2
GRAL
GRAIL, Inc.
$6.88BUSD

Key Statistics

Company
Market Cap10.27B USD
Enterprise Value9.56B USD
Revenue (TTM)4.34B USD
Gross Profit2.51B USD
Net Income (TTM)432.07M USD
Revenue/Share33.91 EUR
Last Price80.10 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees14.6K
CountryFR
SectorHealthcare
IndustryDiagnostics & Research
ISINFR0013280286
Valuation
P/E (Trailing)20.54
P/E (Forward)16.49
PEG1.78
EV/EBITDA8.38
EV/Revenue2.20
P/S2.27
P/B2.10
EPS (TTM)3.90
EPS (Forward)4.66
52W Range
65.6029% of range116.10
52W High116.10 EUR
52W Low65.60 EUR
Profitability
Gross Margin56.73%
Oper. Margin15.23%
EBITDA Margin26.33%
Profit Margin9.77%
ROE9.69%
ROA7.13%
Growth
Revenue Growth-3.90%
Earnings Growth41.90%
Cash Flow & Leverage
Operating CF856.96M USD
CapEx (TTM)364.46M USD
FCF Margin14.77%
FCF Yield6.24%
Net Debt-256.41M USD
Net Debt/EBITDA-0.22
Balance Sheet
Debt/Equity0.11
Current Ratio2.30
Quick Ratio1.44
Book Value/Sh36.51 EUR
Cash/Share5.59 EUR
Dividends
Fwd Div Rate0.98 EUR
Trail. Div Rate0.98 EUR
Div. Yield1.28%
5Y Avg Yield0.83%
Payout Ratio25.13%
Ex-Div DateJun 9, 2026
Pay Date—
Splits
Last Split3:1
Split DateSep 20, 2017
Analyst Consensus
Rating2.6 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)79.54 EUR
Upside (mean)-0.7%
Target Range66.00 EUR – 100.00 EUR
66.00-0.7% to mean100.00
# Analysts14
Ownership
Shares Out.117.95M
Float40.02M
Insiders66.46%
Institutions16.27%
Technical
SMA 5073.83 (+8.5%)
SMA 20082.88 (-3.4%)
Beta0.58
S&P 52W Chg14.58%
Avg Vol (30d)166.95K
Avg Vol (10d)160.35K
Technical Indicators
RSI (14)62.2
MACD1.3062
MACD Signal0.9377
MACD Hist.+0.3685
BB Upper80.55 EUR
BB Middle74.49 EUR
BB Lower68.44 EUR
BB Width16.26%
ATR (14)1.774 EUR
Vol Ratio (20d)0.97x